{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T06:26:18Z","timestamp":1693549578842},"reference-count":20,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Exp Hematopathol","JCEH"],"published-print":{"date-parts":[[2014]]},"DOI":"10.3960\/jslrt.54.219","type":"journal-article","created":{"date-parts":[[2014,12,14]],"date-time":"2014-12-14T23:18:21Z","timestamp":1418599101000},"page":"219-224","source":"Crossref","is-referenced-by-count":9,"title":["B-Cell Prolymphocytic Leukemia Carrying t(8;14)(q24;q32), Associated with Both Autoimmune Hemolytic Anemia and Pure Red Cell Aplasia"],"prefix":"10.3960","volume":"54","author":[{"given":"Futoshi","family":"Iioka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Akasaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Hayashida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuko","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","unstructured":"1 Campo E, Catovsky D, Montserrat E, M\u00fcller-Hermelink HK, Harris NL, <i>et al<\/i>.: B-cell prolymphocytic leukaemia. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, <i>et al<\/i>. (eds): World Health Organization Classification of Tumours, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed, Lyon, International Agency for Research on Cancer (IARC), pp.265-266, 2008"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Dungarwalla M, Matutes E, Dearden CE: Prolymphocytic leukaemia of B- and T-cell subtype: a state-of-the-art paper. Eur J Haematol 80:469-476, 2008","DOI":"10.1111\/j.1600-0609.2008.01069.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Dearden C: How I treat prolymphocytic leukemia. Blood 120:538-551, 2012","DOI":"10.1182\/blood-2012-01-380139"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Hauswirth AW, Skrabs C, Sch\u00fctzinger C, Gaiger A, Lechner K, <i>et al<\/i>.: Autoimmune hemolytic anemias, Evans&apos; syndromes, and pure red cell aplasia in non-Hodgkin lymphomas. Leuk Lymphoma 48:1139-1149, 2007","DOI":"10.1080\/10428190701385173"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Zent CS, Kay NE: Autoimmune complications in chronic lymphocytic leukaemia (CLL). Best Pract Res Clin Haematol 23:47-59, 2010","DOI":"10.1016\/j.beha.2010.01.004"},{"key":"6","unstructured":"6 Vlachaki E, Diamantidis MD, Klonizakis P, Haralambidou-Vranitsa S, Ioannidou-Papagiannaki E, <i>et al<\/i>.: Pure red cell aplasia and lymphoproliferative disorders: an infrequent association. ScientificWorldJournal 2012:475313, 2012"},{"key":"7","unstructured":"7 Hirokawa M, Sawada K, Fujishima N, Kawano F, Kimura A, <i>et al<\/i>.: Acquired pure red cell aplasia associated with malignant lymphomas: a nationwide cohort study in Japan for the PRCA Collaborative Study Group. Am J Hematol 84:144-148, 2009"},{"key":"8","unstructured":"8 ISCN (2009): An International System for Human Cytogenetic Nomenclature (2009). Basel, S. Karger, 2009"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Akasaka T, Muramatsu M, Ohno H, Miura I, Tatsumi E, <i>et al<\/i>.: Application of long-distance polymerase chain reaction to detection of junctional sequences created by chromosomal translocation in mature B-cell neoplasms. Blood 88:985-994, 1996","DOI":"10.1182\/blood.V88.3.985.bloodjournal883985"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Crisostomo RH, Fernandez JA, Caceres W: Complex karyotype including chromosomal translocation (8;14)(q24;q32) in one case with B-cell prolymphocytic leukemia. Leuk Res 31:699-701, 2007","DOI":"10.1016\/j.leukres.2006.06.010"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Kuriakose P, Perveen N, Maeda K, Wiktor A, Van Dyke DL: Translocation (8;14)(q24;q32) as the sole cytogenetic abnormality in B-cell prolymphocytic leukemia. Cancer Genet Cytogenet 150:156-158, 2004","DOI":"10.1016\/j.cancergencyto.2003.09.009"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Lens D, Coignet LJ, Brito-Babapulle V, Lima CS, Matutes E<i>,<\/i> <i>et al<\/i>.: B cell prolymphocytic leukaemia (B-PLL) with complex karyotype and concurrent abnormalities of the p53 and c-MYC gene. Leukemia 13:873-876, 1999","DOI":"10.1038\/sj.leu.2401416"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Merchant S, Schlette E, Sanger W, Lai R, Medeiros LJ: Mature B-cell leukemias with more than 55% prolymphocytes: report of 2 cases with Burkitt lymphoma-type chromosomal translocations involving c-myc. Arch Pathol Lab Med 127:305-309, 2003","DOI":"10.5858\/2003-127-0305-MBCLWM"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Flatley E, Chen AI, Zhao X, Jaffe ES, Dunlap JB, <i>et al<\/i>.: Aberrations of <i>MYC<\/i> are a common event in B-cell prolymphocytic leukemia. Am J Clin Pathol 142:347-354, 2014","DOI":"10.1309\/AJCPUBHM8U7ZFLOB"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Klapproth K, Wirth T: Advances in the understanding of MYC-induced lymphomagenesis. Br J Haematol 149:484-497, 2010","DOI":"10.1111\/j.1365-2141.2010.08159.x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Huh YO, Lin KI, Vega F, Schlette E, Yin CC, <i>et al<\/i>.: MYC translocation in chronic lymphocytic leukaemia is associated with increased prolymphocytes and a poor prognosis. Br J Haematol 142:36-44, 2008","DOI":"10.1111\/j.1365-2141.2008.07152.x"},{"key":"17","unstructured":"17 Put N, Van Roosbroeck K, Konings P, Meeus P, Brusselmans C, <i>et al<\/i>.: Chronic lymphocytic leukemia and prolymphocytic leukemia with MYC translocations: a subgroup with an aggressive disease course. Ann Hematol 91:863-873, 2012"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Love C, Sun Z, Jima D, Li G, Zhang J, <i>et al<\/i>.: The genetic landscape of mutations in Burkitt lymphoma. Nat Genet 44:1321-1325, 2012","DOI":"10.1038\/ng.2468"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Dave SS, Fu K, Wright GW, Lam LT, Kluin P, <i>et al<\/i>.: Molecular diagnosis of Burkitt&apos;s lymphoma. N Engl J Med 354:2431-2442, 2006","DOI":"10.1056\/NEJMoa055759"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Choi JH, Oh YH, Park IK: A case of pure red cell aplasia associated with angioimmunoblastic T-cell lymphoma. Cancer Res Treat 42:115-117, 2012","DOI":"10.4143\/crt.2010.42.2.115"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,4,24]],"date-time":"2022-04-24T11:19:41Z","timestamp":1650799181000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/54\/3\/54_219\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.54.219","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}